Lista de obras -

A Biosafety Agenda to Spur Biotechnology Development and Prevent Accidents

artículo científico publicado en 2017

A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus.

artículo científico publicado en 2018

Addressing the Gap in International Norms for Biosafety

artículo científico publicado en 2015

Analysis of sectoral participation in the development of Joint External Evaluations

article

Anthrax countermeasures: current status and future needs

artículo científico publicado en 2005

Antibiotic resistance

scientific article published on 01 December 2009

Antimicrobial resistance is a global health emergency

artículo científico publicado en 2015

BIOSECURITY. Assessing the bioweapons threat

artículo científico publicado en 2015

Biodefense countermeasures: the impact of Title IV of the US Pandemic and All-Hazards Preparedness Act

artículo científico publicado en 2008

Biodefense in the 21st century

artículo científico publicado en 2017

Biomedical Advanced Research and Development Authority (BARDA) roundtable

artículo científico publicado en 2007

Biosafety laboratories

artículo científico publicado en 2008

Biosecurity Implications for the Synthesis of Horsepox, an Orthopoxvirus

artículo científico publicado en 2017

Bulls, Bears, and Birds: Preparing the Financial Industry for an Avian Influenza Pandemic.

artículo científico publicado en 2005

COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals

artículo científico publicado en 2020

CRISPR Cautions: Biosecurity Implications of Gene Editing

artículo científico publicado en 2020

California shows the way for biosecurity in commercial gene synthesis

artículo científico publicado en 2020

Clade X: A Pandemic Exercise

artículo científico publicado en 2019

Developing medical countermeasures for biodefense

artículo científico publicado en 2009

Does Biotechnology Pose New Catastrophic Risks?

scientific article published on 01 January 2019

Erratum for DiEuliis and Gronvall, "A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus".

artículo científico publicado en 2018

Everywhere You Look: Select Agent Pathogens ⬇️

artículo científico publicado el 1 de marzo de 2011

Expert Views on Biological Threat Characterization for the U.S. Government: A Delphi Study

artículo científico publicado en 2017

Flexible defenses roundtable meeting: promoting the strategic innovation of medical countermeasures

artículo científico publicado en 2007

Getting medicine to millions: New strategies for mass distribution

artículo científico publicado en 2006

Global Catastrophic Biological Risks: Toward a Working Definition

artículo científico publicado en 2017

HHS Guidance on Synthetic DNA Is the Right Step ⬇️

artículo científico publicado el 1 de diciembre de 2010

High-containment biodefense research laboratories: meeting report and center recommendations

artículo científico publicado en 2007

Immune-boosting adjuvants

artículo científico publicado en 2007

Influenza vaccine production for the U.S. market

artículo científico publicado en 2009

Information Hazards in Biotechnology.

artículo científico publicado en 2018

Maintaining US Leadership in Emerging Biotechnologies to Grow the Economy of the Future

artículo científico publicado en 2017

National-level biosafety norms needed for dual-use research

artículo científico publicado en 2014

Navigating the storm: report and recommendations from the Atlantic Storm exercise.

artículo científico publicado en 2005

One health security: an important component of the global health security agenda.

artículo científico publicado en 2014

Options for Synthetic DNA Order Screening, Revisited.

artículo científico publicado en 2017

Preventing the development and use of biological weapons

artículo científico publicado en 2009

Prevention of biothreats: a look ahead

scientific article published on 01 December 2009

Prevention of the Development or Use of Biological Weapons

scientific article published on 16 January 2017

Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency

article

Removing barriers to global pandemic influenza vaccination.

artículo científico publicado en 2006

Reply to "The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards".

artículo científico publicado en 2015

Safety, security, and serving the public interest in synthetic biology

artículo científico publicado en 2018

Shaping the US Bioeconomy for Future Economic Development and Sustainability

artículo científico publicado en 2020

Singapore-Malaysia-Indonesia-US Dialogue on Biosecurity

artículo científico publicado en 2015

Special issue on the global health security agenda

artículo científico publicado en 2014

Strengthening Security for Gene Synthesis: Recommendations for Governance

scientific article published on 22 November 2019

The FDA animal efficacy rule and biodefense

artículo científico publicado en 2007

The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate

artículo científico publicado en 2015

The Scientific Response to COVID-19 and Lessons for Security

artículo científico

The existing guidance for "dual-use" research

artículo científico publicado en 2014

The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence

The science of biodefense: RNAi

scientific article published on 01 June 2007

The scientific response to a pandemic

artículo científico publicado en 2006

U.S. medical countermeasure development since 2001: a long way yet to go.

artículo científico publicado en 2012

US Competitiveness in Synthetic Biology

artículo científico publicado en 2015

iGEM and the Biotechnology Workforce of the Future

artículo científico publicado en 2020

Lista de obras de

A Biosafety Agenda to Spur Biotechnology Development and Prevent Accidents

A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus.

Addressing the Gap in International Norms for Biosafety

Analysis of sectoral participation in the development of Joint External Evaluations

Anthrax countermeasures: current status and future needs

Antibiotic resistance

Antimicrobial resistance is a global health emergency

BIOSECURITY. Assessing the bioweapons threat

Biodefense countermeasures: the impact of Title IV of the US Pandemic and All-Hazards Preparedness Act

Biodefense in the 21st century

Biomedical Advanced Research and Development Authority (BARDA) roundtable

Biosafety laboratories

Biosecurity Implications for the Synthesis of Horsepox, an Orthopoxvirus

Bulls, Bears, and Birds: Preparing the Financial Industry for an Avian Influenza Pandemic.

COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals

CRISPR Cautions: Biosecurity Implications of Gene Editing

California shows the way for biosecurity in commercial gene synthesis

Clade X: A Pandemic Exercise

Developing medical countermeasures for biodefense

Does Biotechnology Pose New Catastrophic Risks?

Erratum for DiEuliis and Gronvall, "A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus".

Everywhere You Look: Select Agent Pathogens ⬇️

Expert Views on Biological Threat Characterization for the U.S. Government: A Delphi Study

Flexible defenses roundtable meeting: promoting the strategic innovation of medical countermeasures

Getting medicine to millions: New strategies for mass distribution

Global Catastrophic Biological Risks: Toward a Working Definition

HHS Guidance on Synthetic DNA Is the Right Step ⬇️

High-containment biodefense research laboratories: meeting report and center recommendations

Immune-boosting adjuvants

Influenza vaccine production for the U.S. market

Information Hazards in Biotechnology.

Maintaining US Leadership in Emerging Biotechnologies to Grow the Economy of the Future

National-level biosafety norms needed for dual-use research

Navigating the storm: report and recommendations from the Atlantic Storm exercise.

One health security: an important component of the global health security agenda.

Options for Synthetic DNA Order Screening, Revisited.

Preventing the development and use of biological weapons

Prevention of biothreats: a look ahead

Prevention of the Development or Use of Biological Weapons

Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency

Removing barriers to global pandemic influenza vaccination.

Reply to "The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards".

Safety, security, and serving the public interest in synthetic biology

Shaping the US Bioeconomy for Future Economic Development and Sustainability

Singapore-Malaysia-Indonesia-US Dialogue on Biosecurity

Special issue on the global health security agenda

Strengthening Security for Gene Synthesis: Recommendations for Governance

The FDA animal efficacy rule and biodefense

The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate

The Scientific Response to COVID-19 and Lessons for Security

The existing guidance for "dual-use" research

The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence

The science of biodefense: RNAi

The scientific response to a pandemic

U.S. medical countermeasure development since 2001: a long way yet to go.

US Competitiveness in Synthetic Biology

iGEM and the Biotechnology Workforce of the Future